Next Generation Surgical Robotics Market (By Component: Systems, Accessories, Services; By Technology: Miniaturized Surgical Robotics, Autonomous Surgical Robotics, Teleoperated Surgical Robotics; By Surgery Type: Gynecology Surgery, Urology Surgery, Neurosurgery, Orthopedic Surgery, General Surgery, Other Surgeries; By End User: Hospitals, Ambulatory Surgical Centers, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Next Generation Surgical Robotics Market 

5.1. COVID-19 Landscape: Next Generation Surgical Robotics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Next Generation Surgical Robotics Market, By Component

8.1. Next Generation Surgical Robotics Market, by Component, 2023-2032

8.1.1. Systems

8.1.1.1. Market Revenue and Forecast (2021-2032)

8.1.2. Accessories

8.1.2.1. Market Revenue and Forecast (2021-2032)

8.1.3. Services

8.1.3.1. Market Revenue and Forecast (2021-2032)

Chapter 9. Global Next Generation Surgical Robotics Market, By Technology

9.1. Next Generation Surgical Robotics Market, by Technology, 2023-2032

9.1.1. Miniaturized Surgical Robotics

9.1.1.1. Market Revenue and Forecast (2021-2032)

9.1.2. Autonomous Surgical Robotics

9.1.2.1. Market Revenue and Forecast (2021-2032)

9.1.3. Teleoperated Surgical Robotics

9.1.3.1. Market Revenue and Forecast (2021-2032)

Chapter 10. Global Next Generation Surgical Robotics Market, By Surgery Type 

10.1. Next Generation Surgical Robotics Market, by Surgery Type, 2023-2032

10.1.1. Gynecology Surgery

10.1.1.1. Market Revenue and Forecast (2021-2032)

10.1.2. Urology Surgery

10.1.2.1. Market Revenue and Forecast (2021-2032)

10.1.3. Neurosurgery

10.1.3.1. Market Revenue and Forecast (2021-2032)

10.1.4. Orthopedic Surgery

10.1.4.1. Market Revenue and Forecast (2021-2032)

10.1.5. General Surgery

10.1.5.1. Market Revenue and Forecast (2021-2032)

10.1.6. Other Surgeries

10.1.6.1. Market Revenue and Forecast (2021-2032)

Chapter 11. Global Next Generation Surgical Robotics Market, By End User 

11.1. Next Generation Surgical Robotics Market, by End User, 2023-2032

11.1.1. Hospitals

11.1.1.1. Market Revenue and Forecast (2021-2032)

11.1.2. Ambulatory Surgical Centers

11.1.2.1. Market Revenue and Forecast (2021-2032)

11.1.3. Others

11.1.3.1. Market Revenue and Forecast (2021-2032)

Chapter 12. Global Next Generation Surgical Robotics Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Component (2021-2032)

12.1.2. Market Revenue and Forecast, by Technology (2021-2032)

12.1.3. Market Revenue and Forecast, by Surgery Type (2021-2032)

12.1.4. Market Revenue and Forecast, by End User (2021-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Component (2021-2032)

12.1.5.2. Market Revenue and Forecast, by Technology (2021-2032)

12.1.5.3. Market Revenue and Forecast, by Surgery Type (2021-2032)

12.1.5.4. Market Revenue and Forecast, by End User (2021-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Component (2021-2032)

12.1.6.2. Market Revenue and Forecast, by Technology (2021-2032)

12.1.6.3. Market Revenue and Forecast, by Surgery Type (2021-2032)

12.1.6.4. Market Revenue and Forecast, by End User (2021-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Component (2021-2032)

12.2.2. Market Revenue and Forecast, by Technology (2021-2032)

12.2.3. Market Revenue and Forecast, by Surgery Type (2021-2032)

12.2.4. Market Revenue and Forecast, by End User (2021-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Component (2021-2032)

12.2.5.2. Market Revenue and Forecast, by Technology (2021-2032)

12.2.5.3. Market Revenue and Forecast, by Surgery Type (2021-2032)

12.2.5.4. Market Revenue and Forecast, by End User (2021-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Component (2021-2032)

12.2.6.2. Market Revenue and Forecast, by Technology (2021-2032)

12.2.6.3. Market Revenue and Forecast, by Surgery Type (2021-2032)

12.2.6.4. Market Revenue and Forecast, by End User (2021-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Component (2021-2032)

12.2.7.2. Market Revenue and Forecast, by Technology (2021-2032)

12.2.7.3. Market Revenue and Forecast, by Surgery Type (2021-2032)

12.2.7.4. Market Revenue and Forecast, by End User (2021-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Component (2021-2032)

12.2.8.2. Market Revenue and Forecast, by Technology (2021-2032)

12.2.8.3. Market Revenue and Forecast, by Surgery Type (2021-2032)

12.2.8.4. Market Revenue and Forecast, by End User (2021-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Component (2021-2032)

12.3.2. Market Revenue and Forecast, by Technology (2021-2032)

12.3.3. Market Revenue and Forecast, by Surgery Type (2021-2032)

12.3.4. Market Revenue and Forecast, by End User (2021-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Component (2021-2032)

12.3.5.2. Market Revenue and Forecast, by Technology (2021-2032)

12.3.5.3. Market Revenue and Forecast, by Surgery Type (2021-2032)

12.3.5.4. Market Revenue and Forecast, by End User (2021-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Component (2021-2032)

12.3.6.2. Market Revenue and Forecast, by Technology (2021-2032)

12.3.6.3. Market Revenue and Forecast, by Surgery Type (2021-2032)

12.3.6.4. Market Revenue and Forecast, by End User (2021-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Component (2021-2032)

12.3.7.2. Market Revenue and Forecast, by Technology (2021-2032)

12.3.7.3. Market Revenue and Forecast, by Surgery Type (2021-2032)

12.3.7.4. Market Revenue and Forecast, by End User (2021-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Component (2021-2032)

12.3.8.2. Market Revenue and Forecast, by Technology (2021-2032)

12.3.8.3. Market Revenue and Forecast, by Surgery Type (2021-2032)

12.3.8.4. Market Revenue and Forecast, by End User (2021-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Component (2021-2032)

12.4.2. Market Revenue and Forecast, by Technology (2021-2032)

12.4.3. Market Revenue and Forecast, by Surgery Type (2021-2032)

12.4.4. Market Revenue and Forecast, by End User (2021-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Component (2021-2032)

12.4.5.2. Market Revenue and Forecast, by Technology (2021-2032)

12.4.5.3. Market Revenue and Forecast, by Surgery Type (2021-2032)

12.4.5.4. Market Revenue and Forecast, by End User (2021-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Component (2021-2032)

12.4.6.2. Market Revenue and Forecast, by Technology (2021-2032)

12.4.6.3. Market Revenue and Forecast, by Surgery Type (2021-2032)

12.4.6.4. Market Revenue and Forecast, by End User (2021-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Component (2021-2032)

12.4.7.2. Market Revenue and Forecast, by Technology (2021-2032)

12.4.7.3. Market Revenue and Forecast, by Surgery Type (2021-2032)

12.4.7.4. Market Revenue and Forecast, by End User (2021-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Component (2021-2032)

12.4.8.2. Market Revenue and Forecast, by Technology (2021-2032)

12.4.8.3. Market Revenue and Forecast, by Surgery Type (2021-2032)

12.4.8.4. Market Revenue and Forecast, by End User (2021-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Component (2021-2032)

12.5.2. Market Revenue and Forecast, by Technology (2021-2032)

12.5.3. Market Revenue and Forecast, by Surgery Type (2021-2032)

12.5.4. Market Revenue and Forecast, by End User (2021-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Component (2021-2032)

12.5.5.2. Market Revenue and Forecast, by Technology (2021-2032)

12.5.5.3. Market Revenue and Forecast, by Surgery Type (2021-2032)

12.5.5.4. Market Revenue and Forecast, by End User (2021-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Component (2021-2032)

12.5.6.2. Market Revenue and Forecast, by Technology (2021-2032)

12.5.6.3. Market Revenue and Forecast, by Surgery Type (2021-2032)

12.5.6.4. Market Revenue and Forecast, by End User (2021-2032)

Chapter 13. Company Profiles

13.1. Medrobotics

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Renishaw plc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. TransEnterix Surgical, Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Intuitive Surgical

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Medtronic plc

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. THINK Surgical Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Zimmer Biomet Holdings Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Smith & Nephew Plc. (Blue Belt Technologies, Inc.)   

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Auris Next generation surgical robotics, Inc. (Hansen Medical Inc.)

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Intuitive Surgical, Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

PROCEED TO BUY :

   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample